Position
Fidelity in Amneal Pharmaceuticals, Inc.
Back to the book · All holders of AMRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3.87M$12.43 → $17.31
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 377K | $4.75M | — | — | — | 0.0% |
| Q1 2026 | 792K | $9.84M | $12.43 | −$64.1K | $5.16M | 0.0% |
| Q2 2026 | 825.1K | $14.3M | $17.31 | $3.87M | $573.1K | 0.0% |